Beyond Fingersticks: Continuous Glucose Monitoring for Inpatient Glycemic Management in a Patient With Type 1 Diabetes and Castleman Disease—A Case Report
Case Reports in Endocrinology · 2026-01 · 2026 (1)
DOI: 10.1155/crie/1901927 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Endocrinology, online erschienen am 14.11.2026. Verfasst von Cristian D Armas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrine and Metabolic Disorders Department of Medicine Macon and Joan Brock Virginia Health Sciences at Old Dominion University Norfolk…. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Continuous glucose monitoring (CGM) provides real‐time interstitial glucose data and may detect glycemic excursions missed by point‐of‐care blood glucose (POC BG) testing. Inpatient evidence remains limited, especially in patients with severe dermatologic disease limiting POC access. We report a 22‐year‐old male with poorly controlled type 1 diabetes and Castleman disease who presented with diffuse pruritic hyperpigmented lesions, mucositis, and nail dystrophy, precluding reliable fingerstick monitoring. During his several‐month hospitalization, he received high‐dose corticosteroids, rituximab, and intravenous immunoglobulin, with marked glycemic variability due to steroid‐induced hyperglycemia, variable intake, and intermittent refusal of care. A Dexcom G7 CGM was initiated to facilitate glucose monitoring, and a single earlobe capillary glucose measurement was obtained at the time of CGM initiation as a reference blood glucose value. CGM data were manually integrated into the electronic medical record (EMR) by nursing staff and used to support insulin titration. Most serum and POC BG measurements did not show major differences from corresponding CGM values. During the first month, time in range (TIR) was 30%, time below range was 2%, and glucose management indicator (GMI) was 8.9%. CGM was used for nearly 3 months during hospitalization, facilitating CGM when POC testing was challenging. The patient later developed respiratory failure, likely due to bronchiolitis obliterans, and died. CGM enabled continuous monitoring when fingersticks were not feasible, supporting insulin adjustment in complex inpatient hyperglycemia. Implementation requires multidisciplinary coordination and validation protocols.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrine and Metabolic Disorders Department of Medicine Macon and Joan Brock Virginia Health Sciences at Old Dominion University Norfolk Virginia USA odu.edu.
ORCID-Profile: Cristian D Armas, Amna Kamran, Manasi Shah
Zitieren
APA
Armas, C. D., Kamran, A., & Shah, M. (2026). Beyond Fingersticks: Continuous Glucose Monitoring for Inpatient Glycemic Management in a Patient With Type 1 Diabetes and Castleman Disease—A Case Report. Case Reports in Endocrinology, 2026(1). https://doi.org/10.1155/crie/1901927
Vancouver
Armas CD, Kamran A, Shah M. Beyond Fingersticks: Continuous Glucose Monitoring for Inpatient Glycemic Management in a Patient With Type 1 Diabetes and Castleman Disease—A Case Report. Case Reports in Endocrinology. 2026;2026(1). doi:10.1155/crie/1901927
BibTeX
@article{Armas2026,
author = {Armas, Cristian D and Kamran, Amna and Shah, Manasi},
title = {Beyond Fingersticks: Continuous Glucose Monitoring for Inpatient Glycemic Management in a Patient With Type 1 Diabetes and Castleman Disease—A Case Report},
journal = {Case Reports in Endocrinology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crie/1901927}
}
EUVIMED